Regenerative therapies using pluripotent stem cell-derived retinal organoids

Abstract

Photoreceptor degeneration leads to irreversible vision loss in numerous inherited retinal diseases. While gene therapy addresses specific mutations, cell replacement strategies offer a potentially broader solution applicable across multiple genetic causes. This review traces the evolution of retinal transplantation approaches, from early fetal tissue transplants to modern pluripotent stem cell-derived retinal organoids. The development of three-dimensional retinal organoids marked a significant advancement, providing transplantable tissue that maintains cellular architecture and relationships. Preclinical studies have demonstrated that transplanted organoids can develop mature photoreceptors with outer segments, form synaptic connections with host bipolar cells, restore light responsiveness in host retinal ganglion cells, and enable light-responsive behaviors in animal models. The first human clinical application using induced pluripotent stem cell-derived retinal organoids has demonstrated safety and stable graft survival over 2 years, with potential functional improvement in one patient at around 1 year after transplantation. Recent innovations include genome-edited retinal organoids with reduced competing bipolar cells, which enhance functional integration by increasing host-graft connectivity. While significant challenges remain, including increasing transplantation area, improving surgical techniques, optimizing patient selection, and addressing manufacturing and regulatory considerations, continued progress in this field may offer hope for some visual improvement in currently untreatable retinal degenerative conditions.

A Simple Temperature‐Controlled Method for Preserving Viability in Human Pluripotent Stem Cell‐Derived Retinal Organoids During Shipment
Karen Cusato, Matthew J. Tarchick, Michael Ha +5
FASEB BioAdvances26 Oct 2026Peer-reviewedCC BYFull textMolecular biology & gene regulationDOAJ
iPSC-derived retinal organoids: Biological insights and progress toward photoreceptor replacement therapy
Akiko Maeda, Xiaoxu Han, Michiko Mandai
Cell Reports Medicine25 Sep 2026Peer-reviewedCC BY 4.0Full textMolecular biology & gene regulationPMC
iPSC-derived RPE and retinal organoids from two phenotypically different Stargardt disease patients show differences in ABCA4 function
Arnau Navinés-Ferrer, Pilar Méndez-Vendrell, Laura Siles +3
iScience28 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulation Cell biologyCell PressCrossrefPMC
Cell-autonomous restoration of splicing homeostasis and RP11 phenotype in patient-derived RPE and retinal organoids by PRPF31.AAV gene therapy
Maria Elia, Valda Pauzuolyte, Maria Georgiou +12
Nature Communications30 Sep 2026Peer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossref
Development-inspired approach for the derivation of functional and transplantable salivary gland organoids from human pluripotent stem cells.
Laura J Sherwood, Ronel Z Samuel, Sai Harsha Bhamidipati +8
Nature communications17 Sep 2026Peer-reviewedCC BY-NC-NDFull textMolecular biology & gene regulationEurope PMC

Cite

BibTeX RIS

BibTeX

@article{mandai2026regenerative,
  title = {{Regenerative therapies using pluripotent stem cell-derived retinal organoids}},
  author = {Michiko Mandai},
  journal = {Taiwan Journal of Ophthalmology},
  year = {2026},
  month = jul,
  doi = {10.4103/tjo.tjo-d-25-00049},
  url = {https://doi.org/10.4103/tjo.tjo-d-25-00049},
  note = {CC BY-NC-ND},
}

RIS

TY  - JOUR
TI  - Regenerative therapies using pluripotent stem cell-derived retinal organoids
AU  - Michiko Mandai
PY  - 2026
DA  - 2026/07/01
JO  - Taiwan Journal of Ophthalmology
DO  - 10.4103/tjo.tjo-d-25-00049
UR  - https://doi.org/10.4103/tjo.tjo-d-25-00049
AB  - Photoreceptor degeneration leads to irreversible vision loss in numerous inherited retinal diseases. While gene therapy addresses specific mutations, cell replacement strategies offer a potentially broader solution applicable across multiple genetic causes. This review traces the evolution of retinal transplantation approaches, from early fetal tissue transplants to modern pluripotent stem cell-derived retinal organoids. The development of three-dimensional retinal organoids marked a significant advancement, providing transplantable tissue that maintains cellular architecture and relationships. Preclinical studies have demonstrated that transplanted organoids can develop mature photoreceptors with outer segments, form synaptic connections with host bipolar cells, restore light responsiveness in host retinal ganglion cells, and enable light-responsive behaviors in animal models. The first human clinical application using induced pluripotent stem cell-derived retinal organoids has demonstrated safety and stable graft survival over 2 years, with potential functional improvement in one patient at around 1 year after transplantation. Recent innovations include genome-edited retinal organoids with reduced competing bipolar cells, which enhance functional integration by increasing host-graft connectivity. While significant challenges remain, including increasing transplantation area, improving surgical techniques, optimizing patient selection, and addressing manufacturing and regulatory considerations, continued progress in this field may offer hope for some visual improvement in currently untreatable retinal degenerative conditions.
SN  - 2211-5056
SN  - 2211-5072
ER  -

Abstract

Related

Cite